Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil's locally produced efavirenz released

This article was originally published in Scrip

Executive Summary

Brazil's health ministry has received the first locally produced batch of the antiretroviral efavirenz after the country issued a compulsory licence for Merck & Co's Stocrin in 2007. The move has proved successful, without deterring investment in Brazil's pharma industry as many had feared, says the ministry.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC000378

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel